Ownership history in Siren, L.L.C. · 6 quarters on record
This page tracks every 13F SEC filing in which Siren, L.L.C. reported a position in Cullinan Therapeutics Inc (CGEM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 1,193,410 | — | 0% | 0.37% | $12.4M | $10.35 |
| 2025 Q3 | UNCHANGED | 1,193,410 | — | 0% | 0.28% | $7.1M | $5.93 |
| 2025 Q2 | UNCHANGED | 1,193,410 | — | 0% | 0.47% | $9.0M | $7.53 |
| 2025 Q1 | REDUCED | 1,193,410 | -17,947 | -1.5% | 0.51% | $9.0M | $7.57 |
| 2024 Q4 | UNCHANGED | 1,211,357 | — | 0% | 0.65% | $14.8M | $12.18 |
| 2024 Q3 | INITIATED | 1,211,357 | — | — | 1.01% | $20.3M | $16.74 |
As of 2025 Q4 — sorted by position size